Syrma Sgs Technology Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

Business Updates View source PDF Explain this filing

SYRMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹528.00

prior close

₹531.90

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.5%-1.2% vs market

Industrial Products peers, median of 104sector+0.3%+0.1% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Smallcap 250 and 0.1 pts more than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

+0.3

15m

+1.2

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4+1.5-1.2+0.3+0.1

Next day

-1.3+2.2-3.5+0.9-2.2

-1.3+1.3-2.6-0.3-1.0

+0.4+1.7-1.3-0.1+0.5

+1.8+1.7+0.1-0.4+2.2

+1.3+2.3-1.0+0.5+0.8

+3.6+3.0+0.6+1.0+2.6

15d

+1.3+7.0-5.6+3.4-2.1

-1.4+7.0-8.5+3.3-4.7

+31.6+11.3+20.4+6.4+25.2

+35.7+4.5+31.2-0.8+36.5

UpDownMarket · Nifty Smallcap 250Sector · Industrial Products peers, median of 104Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syrma SGS Technology has filed its quarterly compliance statement under SEBI Regulation 32(1) for the quarter ended March 31, 2025, confirming that there is no deviation or variation in the use of funds raised through its IPO in August 2022. The company had raised ₹840.13 crores (fresh issue of ₹766 crores + offer for sale of ₹74.13 crores). During the quarter, ₹303.75 crores was utilized towards capital expenditure for R&D facility, expansion, and manufacturing setup against an original allocation of ₹403 crores. Working capital allocation of ₹131.58 crores is nearly fully utilized (₹131.51 crores), and general corporate purpose funds of ₹191.14 crores have been substantially deployed (₹190 crores). The Audit Committee and auditors have no adverse comments, and CRISIL Ratings is the monitoring agency.

Likely market impact

This is a routine regulatory compliance filing with no material impact on shareholders or stock price. It reassures investors that IPO proceeds are being deployed in line with the originally stated objects without any misuse or diversion.